697 Tumor-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

CD28 抗体 T细胞 癌症研究 CD3型 抗原 T细胞受体 细胞毒性T细胞 CD8型 生物 分子生物学 化学 免疫学 体外 免疫系统 生物化学
作者
Michael Hedvat,Veronica G. Zeng,Juan E. Diaz,Christine Bonzon,Kendra N. Avery,Rumana Rashid,Irene Leung,Norm Bartlow,Charles G. Bakhit,Matthew A. Dragovich,Liz Bogaert,Umesh S. Muchhal,John R. Desjarlais,Gregory L. Moore
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:: A419.1-A419 被引量:2
标识
DOI:10.1136/jitc-2020-sitc2020.0697
摘要

Background T cells in the tumor micro-environment require TCR/MHC engagement and co-stimulatory receptor engagement to achieve complete activation. Solid tumors often lack expression of CD28 ligands, so we hypothesized that activation of CD28 signaling could be beneficial in solid tumors. We designed tumor-associated-antigen (TAA) x CD28 bispecific antibodies that conditionally costimulate CD28 only in the presence of TAA and TCR engagement. Clinical application of this class of antibodies has potential to enhance activity of either anti-PD(L)1 antibodies or TAA x CD3 T cell engagers. Methods We designed a stability and affinity optimized anti-CD28 antibody that can be paired with TAA of choice to engage CD28 monovalently using Xencor’s XmAb 2+1 and 1+1 platforms. In vitro T cell activation with these bispecifics was measured by T cell proliferation, cytokine production, and cytotoxicity, in co-cultures of human cancer cell lines mixed with primary human CD3-stimulated T cells. In vitro activity was validated in a CMV recall assay measuring CMV+ T cell proliferation of CMV+ PBMC co-cultured with cancer cell lines ectopically treated with pp65-derived NLV-peptide. In vivo anti-tumor and T cell proliferative activity of B7H3 x CD28 bispecific antibodies were determined in tumor-bearing huPBMC-NSG mice treated simultaneously with TAA x CD3 bispecific antibody. In vivo activity of PDL1 x CD28 antibodies was determined with hCD28 KI mice inoculated with MC38 tumors expressing hPDL1-antigen. Finally, safety and tolerability of B7H3 x CD28 and PDL1 x CD28 was determined in cynomolgus monkeys. Results B7H3 x CD28 and PDL1 x CD28 antibodies enhanced T cell degranulation, cytokine secretion, and cancer cell cytotoxicity in concert with CD3 stimulation only in the presence of target antigen. B7H3 x CD28, alone or in combination with anti-PD1 antibody, enhanced proliferation of CMV+ T cells recognizing cancer cells loaded with pp65-derived NLV peptide. PDL1 x CD28 also enhanced CMV+ cell expansion but did not synergize with anti-PD1 antibody treatment. B7H3 x CD28 significantly enhanced in vivo anti-tumor activity of TAA x CD3 antibodies while also promoting greater T cell expansion. In hCD28 mice inoculated with MC38 tumors expressing hPDL1, PDL1 x CD28 antibody inhibited tumor growth greater than an anti-PDL1 antibody alone. B7H3 x CD28 and PDL1 x CD28 were well tolerated in cynomolgus monkeys. Conclusions B7H3 x CD28 and PDL1 x CD28 bispecific antibodies show promising anti-tumor activity and warrant further development.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
青葙完成签到,获得积分10
1秒前
123456发布了新的文献求助10
2秒前
11NING发布了新的文献求助10
3秒前
Ysk完成签到,获得积分10
3秒前
5秒前
675675发布了新的文献求助10
7秒前
汉堡包的应助被小艾同学采纳,获得10
7秒前
8秒前
11秒前
11NING完成签到,获得积分10
11秒前
11秒前
SCI完成签到,获得积分10
12秒前
Koi发布了新的文献求助10
12秒前
禹hs完成签到,获得积分10
15秒前
吱ing完成签到 ,获得积分10
16秒前
ding的应助被bbb采纳,获得10
16秒前
SCI发布了新的文献求助10
16秒前
ZeSheng完成签到,获得积分10
17秒前
18秒前
18秒前
18秒前
眠龙完成签到 ,获得积分10
19秒前
猪猪侠完成签到,获得积分10
20秒前
20秒前
20秒前
英俊的铭的应助被xxx采纳,获得10
21秒前
水煮电吹风的应助被叶95采纳,获得10
21秒前
ylfs完成签到,获得积分10
21秒前
22秒前
bobo完成签到,获得积分10
23秒前
小艾同学发布了新的文献求助10
23秒前
see发布了新的文献求助10
24秒前
在水一方的应助被LILILILI采纳,获得30
25秒前
嘤嘤嘤完成签到,获得积分10
25秒前
25秒前
999完成签到,获得积分10
25秒前
123完成签到 ,获得积分10
26秒前
香蕉觅云的应助被祥子的骆驼采纳,获得10
27秒前
。。。完成签到,获得积分0
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568